
1. J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27446. [Epub ahead of print]

Analysis by real-time PCR of five transport and conservation mediums of
nasopharyngeal swab samples to COVID-19 diagnosis in Santiago of Chile.

Barrera-Avalos C(1), Luraschi R(1), Vallejos-Vidal E(1)(2), Figueroa M(1),
Arenillas E(1), Barría D(1), Hernández F(1), Mateluna C(1), Mena J(1), Rioseco
C(1), Torrent C(1), Vergara C(1), Gutiérrez G(1), Quiroz J(1), Alarcón J(1),
Cartagena J(1), Cayunao J(1), Mella-Torres A(1), Santibañez Á(1), Tapia S(1),
Undurraga A(1), Vargas D(1), Wong V(1), Inostroza-Molina A(1), Valdés D(1)(3),
Imarai M(1)(3), Acuña-Castillo C(1)(3), Reyes-López FE(1)(4)(5), Sandino
AM(1)(3).

Author information: 
(1)Centro de Biotecnología Acuícola, Facultad de Química y Biología, Universidad 
de Santiago de Chile, Santiago, Chile.
(2)Centro de Nanociencia y Nanotecnología CEDENNA, Universidad de Santiago de
Chile, Santiago, Chile.
(3)Departamento de Biología, Facultad de Química y Biología, Universidad de
Santiago de Chile, Santiago, Chile.
(4)Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de
Barcelona, Bellaterra, Spain.
(5)Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas,
Santiago, Chile.

Due to the COVID-19 pandemic, many transport kits have been manufactured to
preserve and transport nasopharyngeal swab samples (NPSs) from patients. However,
there is no information on the performance of the different virus transport media
(VTM) used in COVID-19 diagnosis in the population of Santiago de Chile. We
compared the RT-qPCR amplification profile of five different viral transport kit 
mediums, including DNA/RNA Shield™, NAT, VTM-N, Ezmedlab™, and phosphate-buffered
saline (PBS), for NPSs from Central Metropolitan Health Service, Santiago, Chile.
The DNA/RNA Shield™ medium showed a better performance in terms of Cq and RFU
values for the internal reference RNase P and viral ORF1ab probes. By contrast,
the PBS transport medium registered higher Cq values for the viral and reference 
gene, compared to the other VTM. DNA/RNA Shield™ shows higher relative
fluorescence units (RFUs) and lower Cq values for the reference gene.
Collectively, our results suggest that the PBS medium could compromise the sample
diagnosis because of its lower RT-qPCR performance. The NAT, Ezmedlab and VTM-N, 
and DNA/RNA Shield™ media show acceptable RT-qPCR parameters and, consequently,
seem suitable for use in COVID-19 diagnosis.

© 2021 Wiley Periodicals LLC.

DOI: 10.1002/jmv.27446 
PMID: 34755352 

